SC 13G

Company

Edesa Biotech, Inc.

Filed

September 24, 2013

Accession Number

0001217160-13-000286

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →